ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 638 • 2015 ACR/ARHP Annual Meeting

    Assessment of Myocardial Abnormalities in Primary Sjögren Syndrome Using a Comprehensive Cardiac Magnetic Resonance Approach

    Natsumi Ikumi1, Hitomi Kobayashi2, Yasuyuki Kobayashi3, Hirotake Inomata4, Yosuke Nagasawa4, Kaita Sugiyama4, Hiromi Karasawa1, Takamasa Nozaki4, Hidetaka Shiraiwa4, Mitsuhiro Iwata2, Noboru Kitamura5, Yoshihiro Matsukawa1 and Masami Takei2, 1Division of Heamatology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan, 2Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan, 3Advanced Biomedical Imaging Informatics, St.Marianna University School of Medicine, Kawasaki, Japan, 4Nihon University School of Medicine, Tokyo, Japan, 5NIhon University School of Medicine, Tokyo, Japan

    Background/Purpose: Primary Sjögren syndrome (pSS) shares many clinical, inflammatory, and immunological features with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). SLE and RA are…
  • Abstract Number: 639 • 2015 ACR/ARHP Annual Meeting

    Association Between Insomnia and EULAR Sjögren’s Syndrome Patient-Reported Index in Korean Patients with Primary Sjögren’s Syndrome

    Jaehyung Hur1, Sang Wan Chung1, You Jung Ha2, Eun Ha Kang3, Yeong Wook Song4 and Yun Jong Lee5, 1Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, South Korea, 2Division of Rheumatology, Department of Internal Medicine,Seoul National University Bundang Hospital, Seongnam, South Korea, 3Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, South Korea, 4Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea, 5Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, South Korea

    Background/Purpose: EULAR Sjögren's syndrome Patient-Reported Index (ESSPRI) is an index to evaluate symptom severity and recommended as an efficacy measure for clinical trials in primary…
  • Abstract Number: 640 • 2015 ACR/ARHP Annual Meeting

    Sjögren’s Syndrome in Male Patients Presents with Higher Autoantibody Levels and More Extraglandular Manifestations

    Jorge Ramírez1,2, Marika Kvarnstrom2,3 and Marie Wahren-Herlenius1,2, 1Department of Medicine, Karolinska Institutet, Solna, Sweden, 2Department of Medicine, Experimental Rheumatology Unit, Solna, Sweden, 3Department of Medicine, Unit of Rheumatology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

    Background/Purpose: Primary Sjögren’s syndrome (pSS) and SLE are chronic autoimmune diseases that predominantly affect women, with a female:male ratio of approximately 9:1. SLE in men…
  • Abstract Number: 641 • 2015 ACR/ARHP Annual Meeting

    Pain, Xerostomia and Younger Age Are Major Determinants of Fatigue in Korean Primary Sjögren’s Syndrome Patients: A Comprehensive Analysis of a Cohort Study

    JungHee Koh1, Seung-Ki Kwok2, Min Kyung Chung3, Jennifer Lee3, Ji Yeon Lee4 and Sung-Hwan Park3, 1Seochogu, Banpodaero, 222, Division of Rheumatology, Department of Internal Medicine, College of Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, South Korea, 2[email protected], Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea, 3Division of Rheumatology, Department of Internal Medicine, College of Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, South Korea, 4Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea

    Background/Purpose: Fatigue is a common clinical manifestation in patients with primary Sjögren¡¯s syndrome (PSS). The aims of this study were to investigate the association between…
  • Abstract Number: 642 • 2015 ACR/ARHP Annual Meeting

    Assignable Causes for Fatigue in Primary Sjögren’s Syndrome: Data from the UK Primary Sjögren’s Syndrome Registry

    Rebecca L Lambson1, Ben Hargreaves2, Dennis W Lendrem2, Victoria Hindmarsh3, Claire Humphrey3, Sheryl Mitchell3, Bridget Griffiths4, Simon Bowman5, UKPSS Registry6 and Wan-Fai Ng7, 1Newcastle University, Medical School, Newcastle upon Tyne, United Kingdom, 2Institute of Cellular Medicine (Musculoskeletal Research Group), NIHR Newcastle Biomedical Research Centre, Newcastle Hospitals Foundation Trust and Newcastle University, Newcastle upon Tyne, United Kingdom, 3Freeman Hospital, Newcastle upon Tyne, United Kingdom, 4Rheumatology, Freeman Hospital, Newcastle Upon Tyne, United Kingdom, 5Rheumatology Dept, University Hospital Birmingham, Birmingham, United Kingdom, 6Newcastle University, Newcastle upon Tyne, United Kingdom, 7NIHR Newcastle Biomedical Research Centre, Newcastle University, Newcastle upon Tyne, United Kingdom

    Background/Purpose: Fatigue is frequently reported as an important symptom in need of management by patients with Primary Sjögren’s Syndrome (SS) [1-3].  It can be severe,…
  • Abstract Number: 643 • 2015 ACR/ARHP Annual Meeting

    Ethnicity of Sjögren’s Syndrome

    Rohan Sharma1, Astrid Rasmussen2, Lida Radfar3, David M. Lewis4, Kiely Grundahl5, C. Erick Kaufman6, Donald U. Stone7, Joan T. Merrill8, Christopher Lessard9, Kathy L. Sivils9 and Robert Hal Scofield10, 1Medical Service, US Department of Veterans Affaris Medical Center, Oklahoma City, OK, 2Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Oral Diagnosis and Radiology Department, University of Oklahoma Health Sciences Center College of Dentistry, Oklahoma City, OK, 4College of Dentistry, Department of Oral and Maxillofacial Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 5Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma CIty, OK, 6Medicine, University of Oklahoam Health Sciences Center, Oklahoma City, OK, 7Ophthalmology, University of Oklahoam Health Sciences Center; Dean McGee Eye Center, Oklahoma City, OK, 8Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 9Oklahoma Medical Research Foundation, Oklahoma City, OK, 10Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation; Department of Medicine, University of Oklahoma Health Sciences Center; US Department of Veterans Affairs Medical Center, Oklahoma City, OK

    Background/Purpose: We undertook this study to describe the racial and ethnic diversity of SS compared to that found among patients with SLE.  SLE is known…
  • Abstract Number: 644 • 2015 ACR/ARHP Annual Meeting

    Predicting the Risk for Lymphoma Development in Sjögren’s Syndrome: An Easy to Use Clinical Tool

    Sofia Fragkioudaki1, Clio Mavragani2 and Haralampos M. Moutsopoulos3, 1Physiology, Medical School of Athens, Department of Physiology, Athens, Greece, 2Physiology, Department of Physiology, School of Medicine, National Kapodistrian University of Athens, Athens, Greece, 3Department of Pathophysiology, Medical School of Athens, Department of Pathophysiology, Athens, Greece

    Background/Purpose: Studies from our and other laboratories have shown that clinical, laboratory and serological features at the first evaluation of a patient with primary Sjogren’s…
  • Abstract Number: 645 • 2015 ACR/ARHP Annual Meeting

    Subclinical Cardiovascular Involvement in Patients with Primary Sjögren Syndrome

    Alberto Batticciotto1, Federica Rigamonti1, Fabiola Atzeni1, Marco Antivalle1, Rossella Talotta1, Laura Boccassini1, Luigi Gianturco2, Maurizio Turiel2, Andrea Doria3 and Piercarlo Sarzi-Puttini1, 1Rheumatology Unit, L. Sacco University Hospital, Milano, Italy, 2Cardiology Unit, IRCCS-Galeazzi Orthopedic Institute, Milan, Italy, 3Department of Medicine-DIMED, University of Padova, Padova, Italy

    Background/Purpose: Different studies showed that systemic inflammation, elevated levels of inflammatory cytokines and immune dysregulation, typical of the inflammatory autoimmune disease, play a role in…
  • Abstract Number: 646 • 2015 ACR/ARHP Annual Meeting

    Sicca Syndrome in Rheumatoid Arthritis: Is It a Real Sjögren’s?

    George Fragoulis1, James Reilly1, Shauna Kerr1, Iain. B. McInnes1 and Haralampos M. Moutsopoulos2, 1Institute of Infection, Immunity and Inflammation, College of Medicine, Veterinary Medicine and Life Sciences, University of Glasgow, Glasgow, United Kingdom, 2Department of Pathophysiology, Medical School of Athens, Department of Pathophysiology, Athens, Greece

    Background/Purpose: The histopathological hallmark and a major diagnostic criterion of Sjögren’s syndrome (SS) is the presence of periductal lymphocytic infiltrates in the labial minor salivary…
  • Abstract Number: 647 • 2015 ACR/ARHP Annual Meeting

    Involvement  of Peripheral Nervous System in Primary Sjögren Syndrome, a Gessar Analysis

    M. Mayer1, S. Velez2, F. Zazzetti2, J. C. Barreira2, L. Galvan1, G. Bennasar3, L. R. Carlevaris3, A. Secco3, C. Asnal4, P. Pucci4, C. Amitrano4, A. Nitsche4, M. C. Khoury5, F. Caeiro6, N. Benzaquén6, J.P. Pirola6, M. Colazo6, O.L. Rillo7, S. Papasidero7, J. Demarchi7, L. Raitti8, M. N. Tamborenea9, M. L. Santiago9, P. Alba10, B. Busamia10, G. Salvatierra11 and A. Catalán Pellet3, 1Rheumatology, Buenos Aires British Hospital, CABA, Argentina, 2Rheumatology, Buenos Aires British Hospital, Buenos Aires, Argentina, 3Rivadavia Hospital, CABA, Argentina, 4German Hospital, CABA, Argentina, 5Statistics, Buenos Aires British Hospital, CABA, Argentina, 6Private Hospital of Cordoba, Cordoba, Argentina, 7Tornú Hospital, CABA, Argentina, 8Bessone Clinic, CABA, Argentina, 9OMI, Buenos Aires, CABA, Argentina, 10Córdoba Hospital, Cordoba, Argentina, 11IPRI, Santiago del Estero, Santiago del Estero, Argentina

    Background/Purpose: Primary Sjögren's syndrome (pSS) is an autoimmune disease characterized by dysfunction of the exocrine glands.  The frequency of neurological manifestations in pSS ranges from…
  • Abstract Number: 648 • 2015 ACR/ARHP Annual Meeting

    Klinefelter’s Syndrome (47,XXY) Among Men with Sjögren’s Syndrome

    Valerie M Harris1, Joshua Cavett2, Biji Kurien3, Ke Liu4, Kristi A. Koelsch5, Lida Radfar6, David M. Lewis7, Donald U. Stone8, Shibo Li9, Barbara Segal10, Daniel J Wallace11, Michael H. Weisman12, Jennifer A. Kelly13, Marta Alarcon-Riquelme14, Bernado Pons-Estel15, Roland Jonsson16, Xianglan Lu9, Jacques Gottenberg17, Juan-Manuel Anaya18, Deborah S. Cunninghame-Graham19, Edward C. Keystone20, Andrew J.W. Huang21, Michael T. Brennan22, Pamela Hughes23, G Illei24, Corinne Miceli25, VP Bykerk26, Gideon Hirschfield27, Gang Xie28, Wan-Fai Ng29, Gunnel Nordmark30, Per Eriksson31, Roald Omdal32, Nelson L. Rhodus33, Maureen Rischmueller34, Michael D. Rohrer35, Marie Wahren-Herlenius36, Torsten Witte37, Xavier Mariette38, Christopher Lessard39, John B. Harley40, Kathy L. Sivils39 and Robert Hal Scofield41, 1Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 2Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 3Arthritis and Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 43333 Burnet Ave., University of Cincinnati & Cincinnati Childre, Cincinnati, OH, 5Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Okalahoma City, OK, 6Oral Diagnosis and Radiology Department, University of Oklahoma Health Sciences Center College of Dentistry, Oklahoma City, OK, 7College of Dentistry, Department of Oral and Maxillofacial Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 8King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia, 9Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 10Rheumatology, Univ of Minnesota, Minneapolis, MN, 11Cedars-Sinai Medical Center, West Hollywood, CA, 12Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, 13Arthritis & Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 14Arthritis & Clinical Immunology, Oklahoma Medical REsearch Foundtion, Oklahoma City, OK, 15Hospital Provincial de Rosario, Rosario, Argentina, 16Broegelmann research laboratory, Bergen, Norway, 17Hautepierre, Strasbourg, France, 18Cell Biol and Immunogenetics, CIB-Rosario University, Medellin, Colombia, 19Department of Medical and Molecular Genetics, King's College London, London, United Kingdom, 20Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, 21Department of Ophthalmology and Visual Sciences, Washington University, St Louis, MO, 22Department of Oral Medicine, Carolinas Medical Center, Charlotte, NC, 23Division of Oral and Maxillofacial Surgery, Department of Developmental and Surgical Science, University of Minnesota School of Dentistry, Minneapolis, MN, 24Sjögren's Clinic, NIDCR/NIH, Bethesda, MD, 25Rheumatology, PARIS, France, 26University of Toronto, Toronto, ON, Canada, 27Centre for Liver Research, Institute of Biomedical Research, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom, 28Mount Sinai Hospital, Toronto, ON, Canada, 29Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom, 30Medical Sciences, Uppsala University, Uppsala, Sweden, 31University Hospital, Rheumatology clinic, Linköping, Sweden, 32Department of internal medicine, Clinical Immunology unit, Stavanger, Norway, 33Department of Oral Surgery, University of Minnesota School of Dentistry, Minneapolis, MN, 34Rheumatology, Queen Elizabeth Hospital, Adelaide, Australia, 35Hard Tissue Research Laboratory, University of Minnesota School of Dentistry, Minneapolis, MN, 36Department of Medicine, Experimental Rheumatology Unit, Solna, Sweden, 37Department of Immunology and Rheumatology, Hannover Medical School, Hannover, Germany, 38Université Paris-Sud, AP-HP, Hôpitaux Universitaires Paris-Sud, Paris, France, 39Oklahoma Medical Research Foundation, Oklahoma City, OK, 40Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 41Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation; Department of Medicine, University of Oklahoma Health Sciences Center; US Department of Veterans Affairs Medical Center, Oklahoma City, OK

    Background/Purpose: Primary Sjögren’s syndrome (pSS) has a strong female bias of greater than 10 to 1. This difference in risk of disease between the sexes…
  • Abstract Number: 649 • 2015 ACR/ARHP Annual Meeting

    Measures of Health-Related Quality of Life in Psoriatic Arthritis: Are They Sensitive to Both Joint and Skin Aspects?

    Mwidimi Ndosi1, Ming-Anne Hsu2, J. Cappelleri3, Amit Chhabra4, Heather Jones5 and Philip S. Helliwell6, 1School of Healthcare, University of Leeds, Leeds, United Kingdom, 2445 Eastern Point Road, Pfizer Inc, Groton, CT, 3Statistics, Pfizer Inc, New London, CT, 4Pfizer Inc, Collegeville, PA, 5Inflammation Global Medical Affairs, Pfizer, Collegeville, PA, 6Section of Musculoskeletal Disease, University of Leeds, Leeds, United Kingdom

    Background/Purpose: Psoriatic Arthritis Quality of Life (PsAQol), Ankylosing Spondylitis Quality of Life (ASQoL), and Dermatology Life Quality Index (DLQI) are tools that assess different aspects of health-related…
  • Abstract Number: 650 • 2015 ACR/ARHP Annual Meeting

    ASDAS-Based Remission Was Less Frequent Than Basdai-Based Remission, and Both Were Related to CRP and Smoking in Early Axial Spondyloarthritis

    Daniel Wendling1, Xavier Guillot2, Laure Gossec3, Clément Prati4, Alain Saraux5 and Maxime Dougados6, 1Université de Franche-Comté, Besançon, France, 2Service de Rhumatologie, CHRU J Minjoz, Besançon, France, 3Rheumatology, Pitié Salpetriere Hospital, Paris, France, 4Service de Rhumatologie, CHU J Minjoz, Besancon, France, 5Rheumatology Department, CHU de la Cavale Blanche, Brest Cedex, France, 6Cochin University Hospital, Paris, France

    Background/Purpose: Remission is the final goal for treat to target strategy in axial spondyloarthritis (axSpA). No clear definition is currently recognized, but ASDAS-CRP inactive state…
  • Abstract Number: 651 • 2015 ACR/ARHP Annual Meeting

    The Prediction of Long-Term Minimal Disease Activity and Its Benefits in Patients with Psoriatic Arthritis

    Philip J. Mease1, Arthur Kavanaugh2, Laura C Coates3, Iain McInnes4, Maja Hojnik5, Ying Zhang6, Jaclyn K. Anderson6, Alex Dorr6 and Dafna Gladman7, 1Rheumatology Research, Swedish Medical Center, Seattle, WA, 2University of California San Diego, La Jolla, CA, 3Leeds Teaching Hospitals Trust, Leeds, United Kingdom, 4University of Glasgow, Institute of Infection Immunity and Inflammation, Glasgow, United Kingdom, 5AbbVie, Ljubljana, Slovenia, 6AbbVie, North Chicago, IL, 7Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada

    Background/Purpose: Minimal disease activity (MDA)1 is a clinically meaningful and comprehensive treatment target for psoriatic arthritis (PsA). The purpose was to determine if baseline (BL)…
  • Abstract Number: 652 • 2015 ACR/ARHP Annual Meeting

    The Performance of Different Classification Criteria Sets for Spondyloarthritis in the Worldwide ASAS-Comospa Study

    Pauline Bakker1, Anna Moltó2, Adrien Etcheto3, Rosaline van den Berg4, Floris van Gaalen1, Robert B. M. Landewé5, Filip van Den Bosch6,7, Maxime Dougados8 and Désirée van der Heijde9, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Rheumatology, Hospital Germans Trias i Pujol, Badalona, Spain, 3Université Paris René Descartes and Hôpital Cochin, Paris, France, 4Leiden University Medical Center, Leiden, Netherlands, 5Rheumatology, University Hospital Maastricht, Maastricht, Netherlands, 6Department of Rheumatology, Ghent University Hospital, Ghent, Belgium, 7Rheumatology, Ghent University Hospital, Ghent, Belgium, 8Cochin University Hospital, Paris, France, 9University Hospital, Maastricht, Netherlands

    The performance of different classification criteria sets for spondyloarthritis in the ASAS-COMOSPA studyBackground/Purpose: Spondyloarthritis (SpA) includes patients with (predominantly) axial spondyloarthritis (axSpA) and patients with…
  • « Previous Page
  • 1
  • …
  • 1730
  • 1731
  • 1732
  • 1733
  • 1734
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology